Streetbeat News

Stock Prices

HOWL

Werewolf Therapeutics, Inc. (HOWL) has updated its cash guidance, indicating sufficient funds through Q1 of 2025. The company is focusing on the development of its clinical assets, WTX-124 and WTX-330, with key updates from their INDUKINETM programs expected in 2024. Interim and preliminary data from Phase 1/1b and Phase 1 clinical trials for these assets are anticipated in the first and second quarters of 2024, respectively.

Portfolio Pulse from Charles Gross

January 08, 2024 | 12:19 pm

CBT

UBS analyst Joshua Spector has downgraded Cabot (NYSE:CBT) from Buy to Neutral and reduced the price target from $90 to $87, indicating a more cautious outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:17 pm

OKTA

Mizuho analyst Gregg Moskowitz has downgraded Okta (NASDAQ:OKTA) from Buy to Neutral and set a price target of $85. This reflects a more cautious stance on the stock's near-term prospects.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:15 pm

KALV

NBBK

STAA

Insiders at STAAR Surgical, KalVista Pharmaceuticals, and NB Bancorp have made significant stock purchases, signaling potential confidence in their respective companies. STAAR Surgical's 10% owner Neal Bradsher acquired shares worth approximately $6.48 million, while KalVista Pharmaceuticals' 10% owner Nimish Shah purchased shares for about $720,543. NB Bancorp Director Muhammad Raza bought shares totaling around $50,031. These transactions may indicate an opportunity for investors to consider these stocks.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 12:13 pm

AMC

CRGE

GMM

The article discusses three oversold tech and telecom stocks with RSI values near or below 30, indicating potential undervaluation. Global Mofy Metaverse Limited (GMM) announced a $10 million follow-on offering, with its stock falling 51% over five days. AMC Entertainment Holdings, Inc. (AMC) disclosed exchange agreements for its common stock in exchange for $22.5 million of its subordinated notes, with its stock falling 17% over five days. Charge Enterprises, Inc. (CRGE) reported downbeat quarterly sales but highlighted growth in its Infrastructure segment, with its stock falling 28% over the past month.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 12:13 pm

IONS

Ionis Pharmaceuticals presented its 2023 achievements and anticipated milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference. The company's progress and future plans are likely to influence investor sentiment and the valuation of its stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:13 pm

TAST

Carrols Restaurant Group, Inc. (NASDAQ:TAST) reported Q4 restaurant sales growth of 5.7% YoY, reaching $470.4M. Burger King and Popeyes, part of Carrols' portfolio, saw comparable sales growth of 7.2% and 7.6% YoY, respectively. Full-year sales rose 8.4% to $1.88B, with Burger King and Popeyes comparable sales up 9.3% and 10.1%. The company expects Q4 adjusted EBITDA to be at or slightly above the high end of the $28M-$32M range, with full-year adjusted EBITDA also at the high end or above the $145M-$149M range.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:13 pm

PBPB

Potbelly Corporation reported preliminary Q4 same-store sales growth of 5.9% to 6.4%. CEO Bob Wright attributed the growth to the successful execution of their Five-Pillar Strategy, with a notable increase in traffic contributing to the rise. The company's average weekly sales also surpassed the high end of their previous guidance.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:10 pm

HIG

JP Morgan analyst Jimmy Bhullar downgraded Hartford Financial Services Group (HIG) from Overweight to Neutral and reduced the price target from $94 to $91.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:09 pm

FIVE

Five Below, Inc. reported a 15.6% increase in holiday sales, reaching $1.16 billion, and expects Q4 results to be in the upper range of its guidance ($1.32B-$1.35B in sales and $3.64-$3.80 in EPS). The company saw a 3.6% increase in comparable sales during the holiday period and is reiterating its EPS outlook. Five Below opened a record 204 net new stores in fiscal 2023 and is focusing on its Triple-Double strategy for further growth.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 12:09 pm